How much funding has F-Star Alpha Limited raised?

F-Star Alpha Limited has raised $10.5M in total funding, most recently a Series A round.

Who are F-Star Alpha Limited's investors?

F-Star Alpha Limited's investors include MP Healthcare Venture Management.

When was F-Star Alpha Limited founded?

F-Star Alpha Limited was founded in 2006.

Where is F-Star Alpha Limited headquartered?

F-Star Alpha Limited is headquartered in Cambridge, United Kingdom.

What industry is F-Star Alpha Limited in?

F-Star Alpha Limited operates in Biotech, Healthcare.

How many employees does F-Star Alpha Limited have?

F-Star Alpha Limited has 11-50 employees.

F-Star Alpha Limited

Closed

Next-generation multispecific antibody therapeutics

Cambridge, United Kingdom · Founded 2006 · $10.5M raised

Biotech

Healthcare

Headquarters: Cambridge
Employees: 11–50
Founded: 2006
Business Model: B2B

Website: f-star.com
Total Funding: $10.5M
Last Round: $10.5M Series AOct 2013
Rounds: 1

About

F-star Therapeutics is a private Cambridge-based biotech company focused on developing next-generation multispecific bispecific antibody therapeutics for cancer and other serious diseases. The company's proprietary tetravalent bispecific antibody platform is clinically validated and patent-protected, enabling novel combinations of immune cell engagement and tumor targeting that conventional antibodies cannot achieve. F-star partners with global pharmaceutical companies through licensing agreements and collaborations to advance immunotherapy and immuno-oncology programs to patients.

Summary

F-Star Alpha Limited is a Biotech company based in Cambridge, United Kingdom, founded in 2006. It has raised $10.5M in total across 1 round, most recently a $10.5M Series A round in Oct 2013. Investors include MP Healthcare Venture Management.